Literature DB >> 10163458

Visual prognosis and sympathetic ophthalmia.

A Ramadan1, R B Nussenblatt.   

Abstract

Sympathetic ophthalmia is probably the ocular disorder best known to practitioners outside of ophthalmology. It is characterized by a bilateral, nonnecrotizing granulomatous panuveitis that occurs after intentional or unintentional trauma to the exciting eye. So far, the identity of the inciting antigen has not been delineated with certainty. The sequelae from sympathetic ophthalmia have declined markedly in this century as a result of earlier diagnosis, use of corticosteroids, and better management of ocular injuries, in large part due to improved surgical techniques. Cases of sympathetic ophthalmia, however, still occur with their severe sight-threatening complications, which impose on ophthalmologists the importance of prompt diagnosis and aggressive treatment in order to achieve good visual outcome.

Entities:  

Mesh:

Year:  1996        PMID: 10163458     DOI: 10.1097/00055735-199606000-00007

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  3 in total

1.  [Sympathetic ophthalmia : Therapy with steroid-free immunosuppressant azathioprine].

Authors:  K Wand; M Straub; C P Lohmann; C S Mayer
Journal:  Ophthalmologe       Date:  2016-10       Impact factor: 1.059

2.  Sympathetic ophthalmia after surgical resection of iridociliary melanoma. A case report.

Authors:  Jose Garcia-Arumi; Marc Montolio Gil; Merce Morral Palau; Antonio Segura Garcia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

Review 3.  Sympathetic ophthalmia: A comprehensive update.

Authors:  Swapnil Parchand; Deepshikha Agrawal; Nikitha Ayyadurai; Aniruddha Agarwal; Anil Gangwe; Shashwat Behera; Priyavat Bhatia; Samyak Mulkutkar; Gulshan Barwar; Ramandeep Singh; Alok Sen; Manisha Agarwal
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.